Form 13-F position report

* DOLBY LABORATORIES INC

Reported by SCHRODER INVESTMENT MANAGEMENT GROUP

DLB CUSIP 25659T107 Manager CIK 0001086619

Reported 971,831 shares, up 366,304 (60.5%) from the prior quarter.

Reported value 73.7%; share count 60.5% vs. the prior quarter.

Added
% of reported 13F value 0.12% This manager · Q4 2021
Shares 971,831 Quarter-end amount reported
Reported value $92,538,000 Fair value at quarter end
Consecutive quarters held 18 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 53286000
2021-12-31 92538000
2022-03-31 80870000
2022-06-30 70713000
2022-09-30 60734000
2022-12-31 71002531
2023-03-31 84356778
2023-06-30 70996539
2023-09-30 56035630
2023-12-31 55989336
2024-03-31 56937297
2024-06-30 60460492
2024-09-30 89065103
2024-12-31 86154588
2025-03-31 83176161
2025-06-30 59917423
2025-09-30 20486536
2025-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

18 quarters
Quarterly reported position history for * DOLBY LABORATORIES INC held by SCHRODER INVESTMENT MANAGEMENT GROUP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Reduced 0 -282,846 (-100.0%) 0 $0 2026-02-13
Q3 2025 Reduced 282,846 -524,014 (-64.9%) 0.02% $20,486,536 2025-11-13
Q2 2025 Reduced 806,860 -234,013 (-22.5%) 0.05% $59,917,423 2025-08-13
Q1 2025 Reduced 1,040,873 -62,824 (-5.7%) 0.08% $83,176,161 2025-05-13
Q4 2024 Reduced 1,103,697 -74,257 (-6.3%) 0.08% $86,154,588 2025-02-12
Q3 2024 Added 1,177,954 +414,853 (54.4%) 0.09% $89,065,103 2024-11-13
Q2 2024 Added 763,101 +83,415 (12.3%) 0.07% $60,460,492 2024-08-12
Q1 2024 Added 679,686 +30,007 (4.6%) 0.07% $56,937,297 2024-05-14
Q4 2023 Reduced 649,679 -57,306 (-8.1%) 0.07% $55,989,336 2024-02-14
Q3 2023 Reduced 706,985 -141,444 (-16.7%) 0.08% $56,035,630 2023-11-14
Q2 2023 Reduced 848,429 -139,124 (-14.1%) 0.1% $70,996,539 2023-08-11
Q1 2023 Reduced 987,553 -19,004 (-1.9%) 0.13% $84,356,778 2023-05-11
Q4 2022 Added 1,006,557 +74,332 (8.0%) 0.11% $71,002,531 2023-02-10
Q3 2022 Reduced 932,225 -40,581 (-4.2%) 0.1% $60,734,000 2022-11-14
Q2 2022 Reduced 972,806 -57,646 (-5.6%) 0.11% $70,713,000 2022-08-11
Q1 2022 Added 1,030,452 +58,621 (6.0%) 0.11% $80,870,000 2022-05-16
Q4 2021 Added 971,831 +366,304 (60.5%) 0.12% $92,538,000 2022-02-14
Q3 2021 Reduced 605,527 -65,804 (-9.8%) 0.08% $53,286,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

413 managers reported * DOLBY LABORATORIES INC for Q4 2021.

Managers reporting * DOLBY LABORATORIES INC in Q4 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 6,157,704 +7,488 0.01% $586,337,000 35 qtrs
ATLANTA CAPITAL MANAGEMENT CO L L C Added 3,525,296 +257,199 1.14% $335,679,000 8 qtrs
BlackRock Inc Reduced 3,427,423 -297,258 < 0.01% $326,361,000 35 qtrs
Clearbridge Investments LLC Reduced 3,372,687 -64,116 0.22% $321,147,000 35 qtrs
Jackson Square Partners LLC Added 3,228,356 +497,125 2.58% $307,404,000 5 qtrs
SOMA EQUITY PARTNERS LP Unchanged 2,300,000 0 6.63% $219,006,000 6 qtrs
JANUS HENDERSON GROUP PLC Reduced 1,966,318 -144,325 0.08% $187,233,000 23 qtrs
Ninety One UK Ltd Added 1,686,493 +1,483,012 0.38% $160,588,000 2 qtrs
MACKENZIE FINANCIAL CORP Added 1,656,550 +219,914 0.21% $157,737,000 16 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Added 1,634,004 +325,763 0.03% $155,591,000 35 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
February 14, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
971,831
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.